Latest Cancer vaccine Stories
The Encore at Wynn Las Vegas: September 11th, 2014 ZUG, Switzerland and NEW YORK, Sept.
Horses with melanoma are the subject of this major clinical study TAMPA, Fla., Sept.
Unique Multivalent WT1 Vaccine to be developed across hematological malignancies and solid tumors NEW YORK, Sept.
Key Program Part of Recent Merger with MabVax Therapeutics, Inc. SAN DIEGO, Aug. 28, 2014 /PRNewswire/ -- Telik, Inc.
WHITE PLAINS, N.Y., Aug.
Contract Results from Recent Merger with MabVax Therapeutics, Inc. SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Telik, Inc.
Initial Closing is for $10 Million FREDERICK, Md., Aug.
MicroVAX, LLC, National Cancer Center (NCC), Singapore, and Singapore Clinical Research Institute (SCRI) joint media release, August 12, 2014 Manassas, Virginia
TAMPA, Fla., Aug.
Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the Antigen Express Novel Immunotherapeutic AE37 WORCESTER, Mass.
- Emitting flashes of light; glittering.